Axsome Therapeutics, Inc. (AXSM) Executive Compensation
Axsome Therapeutics, Inc. (AXSM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AXSM
CIK: 1579428
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerMichael Makovec
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-03 | 2026-09-03 | 4 | 0001193125-26-382277 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001958244-26-000571 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-342360 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-341206 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | 4 | 0001193125-26-340688 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001958244-26-000491 | View SEC Doc Filr Page |
| 144 | 2026-08-05 | — | 144 Filing | 0001958244-26-000488 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002197 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-15 | 8-K | 0001193125-26-304039 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-07-01 | 4 | 0001193125-26-292985 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001958244-26-000417 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-268202 | View SEC Doc Filr Page |
| 144 | 2026-06-11 | — | 144 Filing | 0001921094-26-000636 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | 4 | 0001193125-26-266437 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | 4 | 0001193125-26-266436 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | 4 | 0001193125-26-266435 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | 4 | 0001193125-26-266433 | View SEC Doc Filr Page |
| 144 | 2026-06-10 | — | 144 Filing | 0001921094-26-000633 | View SEC Doc Filr Page |
| 144 | 2026-06-10 | — | 144 Filing | 0001921094-26-000632 | View SEC Doc Filr Page |
| 144 | 2026-06-10 | — | 144 Filing | 0001921094-26-000631 | View SEC Doc Filr Page |
| 144 | 2026-06-09 | — | 144 Filing | 0001958244-26-000358 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-05 | 8-K | 0001193125-26-264047 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-05 | 8-K | 0001193125-26-264043 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264041 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 | 0001193125-26-264040 | View SEC Doc Filr Page |